Offer - Urjas Oil for just ₹ 1 X
Clonil 50 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Obsessive Compulsive Disorder.
The correct dosage of Clonil 50 Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Clonil 50 Tablet as well, which are listed below. Usually, these side effects of Clonil 50 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Clonil 50 Tablet is Moderate for pregnant women and Severe for women who are breastfeeding. In addition, Clonil 50 Tablet's effects on the liver, heart and kidney are discussed below in the Clonil 50 Tablet related warnings section.
Individuals suffering from medical conditions like Heart Disease, Coronary Artery Disease (CAD), Suicidal Tendency must refrain from the use of Clonil 50 Tablet since this can cause severe adverse effects. Other contraindications of Clonil 50 Tablet have been discussed in the sections ahead.
Besides this, Clonil 50 Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Clonil 50 Tablet is considered not safe while driving, and is not addictive.
Clonil 50 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Clonil 50 Tablet safe for pregnant women?
Clonil may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Clonil again without your doctor's advice.
Is the use of Clonil 50 Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Clonil. So it is adviced to consult the doctor before using it.
What is the effect of Clonil 50 Tablet on the Kidneys?
Clonil does not damage the kidneys.
What is the effect of Clonil 50 Tablet on the Liver?
Side effects of Clonil rarely affect the liver.
What is the effect of Clonil 50 Tablet on the Heart?
Side effects of Clonil rarely affect the heart.
Clonil 50 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Clonil 50 Tablet unless your doctor advises you to do so -
Is this Clonil 50 Tablet habit forming or addictive?
No, you will not get addicted to Clonil 50 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Clonil 50 Tablet can make you feel drowsy.
Is it safe?
Yes, Clonil 50 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, Clonil 50 Tablet is useful in treating mental disorders.
Interaction between Food and Clonil 50 Tablet
You can take Clonil 50 Tablet with food.
Interaction between Alcohol and Clonil 50 Tablet
Taking alcohol with Clonil 50 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Anafranil® (clomipramine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 454, 456, 458, 464